• Regulation of Artificial Intelligence in Health Care and Biomedicine-Reply

    Haider Warraich, Troy Tazbaz, Robert M Califf

    JAMA . 2025 Feb 20. doi: 10.1001/jama.2024.26606. Online ahead of print.

    The US Food and Drug Administration (FDA) is committed to including patient perspectives in the development and evaluation of all medical products, and AI- and machine learning (ML)–enabled products are no different.